Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
Naohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 5, pp. 1495-1506
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 367
Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Yoshikatsu Kanai
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107964-107964
Closed Access | Times Cited: 157
Clinical development of metabolic inhibitors for oncology
Kathryn M. Lemberg, Sadakatali S. Gori, Takashi Tsukamoto, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 1
Open Access | Times Cited: 99
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 20
Tryptophan and its metabolites in normal physiology and cancer etiology
Lizbeth Perez‐Castro, R. Bayes Garcia, Niranjan Venkateswaran, et al.
FEBS Journal (2021) Vol. 290, Iss. 1, pp. 7-27
Open Access | Times Cited: 66
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Yue Zheng, Yiran Yao, Tongxin Ge, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 25
Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 13
SLC7A5 is required for cancer cell growth under arginine-limited conditions
Kyle Dunlap, Austin Bender, Alexis Bowles, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115130-115130
Open Access | Times Cited: 1
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment
Jingshun Zhang, Ying Xu, Dandan Li, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 61
Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
Lili Quan, Ryuichi Ohgaki, Saori Hara, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 58
ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
Catarina Lopes, Carina Pereira, Rui Medeiros
Cancers (2021) Vol. 13, Iss. 2, pp. 203-203
Open Access | Times Cited: 48
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
Xia Pu, Anna Dubrovska
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
Maihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy
Junji Furuse, Masafumi Ikeda, Makoto Ueno, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 3990-3995
Closed Access | Times Cited: 6
L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity
Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 937-953
Open Access | Times Cited: 5
Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
Yann Cormerais, Marina Pagnuzzi‐Boncompagni, Sandra Schrötter, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 4, pp. 2711-2718
Open Access | Times Cited: 38
Oncology Therapeutics Targeting the Metabolism of Amino Acids
Nefertiti Muhammad, Hyun Min Lee, Jiyeon Kim
Cells (2020) Vol. 9, Iss. 8, pp. 1904-1904
Open Access | Times Cited: 38
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Mariafrancesca Scalise, Lara Console, Filomena Rovella, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2028-2028
Open Access | Times Cited: 34
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Keeley G. Hewton, Amritpal S. Johal, Seth J. Parker
Metabolites (2021) Vol. 11, Iss. 2, pp. 112-112
Open Access | Times Cited: 31
Self-assembled nanoparticles with bilirubin/JPH203 alleviate imiquimod-induced psoriasis by reducing oxidative stress and suppressing Th17 expansion
Xinyu Jiang, Qing Yao, Xing Xia, et al.
Chemical Engineering Journal (2021) Vol. 431, pp. 133956-133956
Closed Access | Times Cited: 31
Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 20, pp. 5246-5256
Open Access | Times Cited: 22
LAT1, a novel pharmacological target for the treatment of glioblastoma
Natalia Cappoli, Michael D. Jenkinson, Cinzia Dello Russo, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115103-115103
Closed Access | Times Cited: 20
Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches
Sebastian Jakobsen, Carsten Uhd Nielsen
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 197-197
Open Access | Times Cited: 4
Comprehensive Characterization of LAT1 Cholesterol-Binding Sites
Keino Hutchinson, Avner Schlessinger
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 8, pp. 3349-3358
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top